Peak Bio (PKBO) has released an update to notify the public and investors about the unregistered sales of equity securities.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Peak Bio, Inc. has engaged in a series of financings through convertible promissory notes, raising $1,000,000 initially and an additional $1,175,000 through subsequent closings. These convertible notes, carrying a 10% annual interest rate and a 12-month maturity, offer investors a potential automatic conversion into common stock if a business combination occurs, or an optional conversion at a discounted rate if the company’s stock is publicly traded by the maturity date. Convertible Note Investors are also promised registration rights equivalent to future investors in the next equity financing round.
For further insights into PKBO stock, check out TipRanks’ Stock Analysis page.
For a comprehensive understanding of the announcement, you can read the full document here.
